$102.45 0.00 (%) Gilead Sciences Inc - NASDAQ

Jan. 28, 2015 | 04:00 PM

Partner Headlines

  1. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD | Jan. 28, 2015 | 15:35PM EST
  2. AmerisourceBergen Hits New High On Earnings, Outlook

    IBD | Jan. 28, 2015 | 13:45PM EST
  3. Gilead expands Sovaldi to pill

    IBD | Jan. 26, 2015 | 18:39PM EST
  4. Alibaba Is A Favorite Holding Even For U.S.-Focused Funds

    Benzinga | Jan. 26, 2015 | 14:22PM EST
  5. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 26, 2015 | 07:14AM EST
  6. Gilead Sciences Still has More Upside

    GuruFocus | Jan. 22, 2015 | 15:28PM EST
  7. Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition?

    GuruFocus | Jan. 22, 2015 | 12:32PM EST
  8. Hep C price cuts a concern

    IBD | Jan. 21, 2015 | 18:42PM EST
  9. Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences

    Benzinga | Jan. 21, 2015 | 16:27PM EST
  10. Gilead, AbbVie Hepatitis C Price Cuts Will Hit Sales

    IBD | Jan. 21, 2015 | 12:55PM EST
  11. The 5 Biggest Biotech Stocks

    Benzinga | Jan. 20, 2015 | 16:43PM EST
  12. Why Drug Pricing Could Bring Volatility To The Biotech Sector This Year

    Benzinga | Jan. 20, 2015 | 16:21PM EST
  13. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD | Jan. 20, 2015 | 11:20AM EST
  14. United Therapeutics Clears Hypertension Drug Hurdles

    IBD | Jan. 16, 2015 | 18:44PM EST
  15. Aetna picks Gilead hep C drugs

    IBD | Jan. 16, 2015 | 18:35PM EST
  16. Aetna Sides With Gilead In Hepatitis C Drug Battle

    IBD | Jan. 16, 2015 | 15:43PM EST
  17. Nomura's Takeaways From Meeting With Gilead Sciences' Management

    Benzinga | Jan. 16, 2015 | 10:17AM EST
  18. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  19. Gilead Sciences' Sovaldi Patent Application Rejected In India

    Benzinga | Jan. 14, 2015 | 13:08PM EST
  20. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  21. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  22. Stocks Turn Negative; Goodyear Triggers Sell Signal

    IBD | Jan. 13, 2015 | 15:10PM EST
  23. AbbVie Inc.'s Forthcoming Future Looks Optimistic

    GuruFocus | Jan. 13, 2015 | 14:55PM EST
  24. A Look At 3 Biotech Stocks With Upside Potential

    Benzinga | Jan. 12, 2015 | 16:25PM EST
  25. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  26. Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand ...

    GuruFocus | Jan. 11, 2015 | 00:45AM EST
  27. Weak Revenue Growth Seen

    IBD | Jan. 9, 2015 | 18:39PM EST
  28. Crude Awakening As Energy Squeezes Overall Q4 Profit

    IBD | Jan. 9, 2015 | 17:58PM EST
  29. AbbVie Stock Down After Guidance, Downgrade

    IBD | Jan. 9, 2015 | 11:49AM EST
  30. Five Stock Picks for the New Year

    FoxBusiness | Jan. 8, 2015 | 15:00PM EST
  31. Gilead Sciences Gains Orphan Drug Status For Liver Treatment, Shares Move Higher

    Benzinga | Jan. 7, 2015 | 11:27AM EST
  32. Gilead buys liver drug program

    IBD | Jan. 6, 2015 | 18:31PM EST
  33. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus | Jan. 6, 2015 | 12:46PM EST
  34. Gilead Strikes Deal with CVS, Hits Back AbbVie

    GuruFocus | Jan. 6, 2015 | 12:22PM EST
  35. Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

    Benzinga | Jan. 6, 2015 | 12:21PM EST
  36. Walgreen Year-End Sales Jump On Flu Prescriptions

    IBD | Jan. 6, 2015 | 11:39AM EST
  37. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD | Jan. 6, 2015 | 11:20AM EST
  38. CNBC's Stock Pops & Drops From January 5

    Benzinga | Jan. 5, 2015 | 19:36PM EST
  39. Hepatitis Drugs Vie For Share

    IBD | Jan. 5, 2015 | 18:44PM EST
  40. CVS Covering Gilead HCV Drugs, Countering AbbVie

    IBD | Jan. 5, 2015 | 18:21PM EST
  41. Stocks Lose More Ground; Gilead Sciences Rises

    IBD | Jan. 5, 2015 | 15:10PM EST
  42. CVS Picks Gilead Hep C Drugs As Price War Looms

    IBD | Jan. 5, 2015 | 15:09PM EST
  43. Gilead Sciences Spikes Amid CVS Formulary Status

    Benzinga | Jan. 5, 2015 | 12:32PM EST
  44. Alexion Pharma Downgraded Despite Progress in Pipeline

    GuruFocus | Jan. 5, 2015 | 11:21AM EST
  45. These Were The 10 Most Traded Stocks Of 2014

    Benzinga | Jan. 3, 2015 | 15:08PM EST
  46. The Struggles Of Gilead Sciences

    Benzinga | Dec. 31, 2014 | 13:38PM EST
  47. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  48. Gilead Sciences Seen Benefiting From Hep C Market

    IBD | Dec. 29, 2014 | 15:34PM EST
  49. Mid-Afternoon Market Update: Crude Oil Slides 3%; Gilead Sciences Shares Spike Higher

    Benzinga | Dec. 29, 2014 | 15:27PM EST
  50. Morgan Stanley Upgrades Gilead Sciences, Says It Will Maintain 75% Market Share

    Benzinga | Dec. 29, 2014 | 15:08PM EST
Trading Center